Related Experiment Video

Updated: Aug 2, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Decreased Mdm2 expression inhibits tumor development induced by loss of ARF

P Wang1, T C Greiner, T Lushnikova

  • 1Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, 68198, USA.

Oncogene
|February 24, 2006
PubMed

Insights

Reducing Mdm2 levels in ARF-null cells suppressed tumor growth and extended survival in mice. This suggests targeting Mdm2 is a promising therapeutic strategy for ARF-deficient tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tumor suppressor p14/p19(ARF) regulates Mdm2, a key controller of the p53 tumor suppressor.
  • Loss of ARF function is implicated in various cancers, often leading to uncontrolled cell proliferation and tumor formation.

Purpose of the Study:

  • To investigate the impact of reduced Mdm2 levels on cellular processes and tumor development in the absence of ARF.
  • To determine if Mdm2 can be targeted therapeutically in ARF-deficient tumors.

Main Methods:

  • Utilizing genetically modified mice lacking ARF and varying Mdm2 allele status (Mdm2(+/-)ARF(-/-) vs. Mdm2(+/+)ARF(-/-)).
  • Assessing cellular proliferation rates, chromosomal aberrations, and Ras-induced transformation.
  • Monitoring spontaneous tumor development and survival rates.

Main Results:

  • Haploinsufficiency of Mdm2 in ARF-null cells decreased proliferation, reduced chromosomal aberrations, and suppressed Ras-induced transformation.
  • Mdm2 haploinsufficiency significantly inhibited spontaneous tumor development and extended survival in ARF-null mice.
  • While tumor spectrum was similar, Mdm2 haploinsufficiency led to multiple primary tumors in a subset of mice due to extended latency.

Conclusions:

  • Decreased Mdm2 levels restore regulation of critical cellular processes disrupted by ARF loss.
  • Mdm2 functions independently of ARF, and its targeting represents a viable therapeutic strategy for tumors lacking ARF expression.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...